WHO ICTRP trial
Study on miR21--ECP--IL-4 network and miR21 target gene regulation mechanism of…
ITMCTR2000003471 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Recruiting
Key facts
| Trial ID | ITMCTR2000003471 |
|---|---|
| Public title | Study on miR21--ECP--IL-4 network and miR21 target gene regulation mechanism of allergic rhinitis with Qi deficiency and Blood stasis syndrome by Ke-Min-Qi-Dan nasal spray |
| Scientific title | To explore the regulation mechanism of the target gene miR21 and miR21--ECP--IL-4 network of allergic rhinitis with qi deficiency and blood stasis syndrome by Ke-Min-Qi-Dan nasal spray: a single-center, prospective, randomized controlled clinical trial |
| Primary sponsor | The Hospital of Chengdu University of Chinese Medicine |
| Registry | International Traditional Medicine Clinical Trial Registry (ITMCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | allergic rhinitis with qi deficiency and blood stasis syndrome |
| Interventions | experimental group:Ke-Min-Qi-Dan nasal spray;Health groups:No processing;control group:Normal saline nasal spray |
| Registration date | Jul 6, 2020 |
| Target size | experimental group:10;Health groups:8;control group:10 |
| Secondary IDs | ChiCTR2000034488;ChiMCTR2000003471 |
| Registry page | itmctr.ccebtcm.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: